Privia Health (US:PRVA)2026-02-26 14:02Financial Data and Key Metrics Changes - Privia Health reported a 16.9% increase in practice collections for 2025, reaching $3.47 billion, with adjusted EBITDA growing 38.8% to $125.5 million [6][12][13] - The adjusted EBITDA margin as a percentage of Care Margin expanded by 480 basis points to 27.2% [6][11] - The company ended 2025 with a cash balance of $479.7 million, with a conversion of 130% of EBITDA to free cash flow [7][13] Business Line Data and Key Metrics Changes - The number of implemented providers increased by 12.3% year-over-year to 5,380, with a total of 1.54 million value-based attributed lives, up 22.7% [6][8] - Practice collections in Q4 increased by 9.6% year-over-year, reaching $868.7 million [11] - The company added over 120,000 value-based attributed lives through the acquisition of Evolent Health's ACO business [6][8] Market Data and Key Metrics Changes - Commercial attributed lives increased by more than 16% to 910,000, while lives attributed to CMS Medicaid programs rose by 52% [9] - Medicare Advantage and Medicaid attribution increased by 15% and 23%, respectively, from the previous year [9] Company Strategy and Development Direction - Privia Health aims to achieve the Quadruple Aim: better outcomes, lower costs, improved patient experience, and happier providers [5] - The company plans to continue its growth strategy by actively seeking business development deals in both new and existing markets [15] - The national footprint now includes a presence in 24 states and the District of Columbia, with a focus on maintaining high gross provider retention of 98% [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to drive EBITDA growth of approximately 20% in 2026, with expectations to convert 80% of EBITDA to free cash flow [7][15] - The management highlighted the importance of navigating the changing healthcare regulatory environment and maintaining a diversified business model [16] - There is an expectation of continued elevated ambulatory utilization, which is seen as beneficial for the business [32] Other Important Information - The company completed the acquisition of Evolent Health's ACO business on December 5, which is expected to enhance its value-based care offerings [6][8] - Management emphasized the importance of AI investments to enhance operational efficiency and improve margins [18][19] Q&A Session Summary Question: Can you speak to tech investments, including AI and advancements for physicians? - Management highlighted three components of AI-related investments, focusing on enhancing margins and shareholder returns through data utilization [18][19] Question: Can you provide color on Practice Collection trends for Q4 and 2026 guidance? - Management noted that Q4 collections were impacted by prior period adjustments and that 2026 guidance does not assume similar growth rates [25][26] Question: What are your thoughts on utilization trends and changes around ACA and Medicaid enrollment? - Management expects ambulatory utilization to remain elevated, while acknowledging potential churn in the Medicaid population [32][33] Question: Can you help bridge historical expectations for EBITDA to free cash flow conversion? - Management confirmed an expectation of 80% conversion for 2026, factoring in cash taxes [36][40] Question: Any updated thoughts around capital deployment priorities? - Management reiterated a focus on deploying capital to compound the business while maintaining a sufficient cash balance for flexibility [42][44] Question: Can you provide an update on the Evolent acquisition and its synergies? - Management expressed excitement about the Evolent acquisition and the potential for cross-selling opportunities [50][51] Question: How do you plan to increase the savings rate for the Evolent ACO? - Management indicated that improvements will take time and will involve implementing best practices from Privia's existing operations [54][56] Question: What is the expected impact of the LEAD Model on Privia's strategy? - Management is evaluating the LEAD Model and sees potential opportunities as ACO REACH sunsets [89]